Eftyhia Vardas

Q: What Schools Are Affiliated With Eftyhia Vardas

Eftyhia Vardas is affiliated with the following schools: Stanford University, University of Pittsburgh, University of the Witwatersrand

Eftyhia Vardas's AcademicInfluence.com Rankings

Eftyhia Vardas

Computer Science

#13089

World Rank

#14050

Historical Rank

Artificial Intelligence

#6542

World Rank

#6664

Historical Rank

Database

#10214

World Rank

#10848

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Eftyhia Vardas Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Eftyhia Vardas FC Path is an honorary extraordinary professor in medical virology at the Department of Medical Virology, University of Stellenbosch, and head of virology at Lancet Laboratories in Johannesburg. She is a member of the COVID-19 Ministerial Advisory Committee to the South African minister of health.

(See a Problem?)

Eftyhia Vardas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. (2011) (1012)
Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States (2004) (269)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. (2010) (255)
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity. (2007) (118)
Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old (2011) (110)
Beyond the Checklist: Assessing Understanding for HIV Vaccine Trial Participation in South Africa (2006) (103)
External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. (2011) (96)
Preimmunization epidemiology of hepatitis B virus infection in South African children (1999) (79)
Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans. (2003) (66)
Sequence analysis of the nucleocapsid gene of measles virus isolates from South Africa identifies a new genotype. (1997) (64)
Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population. (2012) (60)
Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses. (2002) (50)
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. (2013) (50)
HIV-1 Tat-based vaccines: from basic science to clinical trials. (2002) (50)
Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults (2011) (41)
The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. (2001) (40)
A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus. (2010) (39)
Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay (2001) (39)
Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia. (1999) (37)
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects. (2012) (37)
Ethical issues in HIV vaccine trials in South Africa. (2000) (36)
GB virus C prevalence in blood donors and high risk groups for parenterally transmitted agents from Gauteng, South Africa† (1998) (35)
The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions. (2000) (34)
Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. (1999) (34)
The epidemiology of respiratory syncytial virus (RSV) infections in South African children. (1999) (29)
Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries: A South African Example (2007) (28)
Effect of human immunodeficiency virus infection on episodes of diarrhea among children in South Africa (2000) (28)
Cross-Clade Reactivity of HIV-1-Specific T-cell Responses in HIV-1-Infected Individuals From Botswana and Cameroon (2006) (20)
Intra- and Inter-clade Cross-reactivity by HIV-1 Gag Specific T-Cells Reveals Exclusive and Commonly Targeted Regions: Implications for Current Vaccine Trials (2011) (17)
Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. (2010) (15)
Evaluation of a rapid human immunodeficiency virus test at two community clinics in Kwazulu-Natal. (2002) (14)
Preparing for phase II/III HIV vaccine trials in Africa. (2005) (13)
HIV vaccine trials in South Africa--some ethical considerations. (2000) (12)
Sexual risk behaviour of the first cohort undergoing screening for enrolment into Phase I/II HIV vaccine trials in South Africa (2009) (10)
Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township (2012) (9)
Case Report and Molecular Analysis of Subacute Sclerosing Panencephalitis in a South African Child (1999) (9)
Progress towards developing a vaccine to prevent HIV and AIDs in South Africa. (2001) (7)
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses. (2012) (7)
Molecular Characterization of HIV-1 Subtype C gp-120 Regions Potentially Involved in Virus Adaptive Mechanisms (2014) (6)
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events (2012) (5)
HIV Testing Using Dried Blood Spots (2002) (4)
HIV and drug use among arrestees in Cape Town Durban and Johannesburg South Africa (Phase 1). (2000) (3)
Hepatitis GBV-C in South Africa. (1997) (3)
Measles virus transmission from infected to immune individuals--implications for measles control and elimination. (1997) (3)
Characterization of variable regions of the Gp120 protein from HIV-1 subtype C virus variants obtained from individuals at different disease stages in Sub-Saharan Africa (2012) (2)
Clinical virology in South Africa : letters (2000) (2)
A new antigen scanning strategy to monitor T-cell immune responses. (2008) (0)
Product news Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males (2013) (0)
Characterization of HIV-1 genetic diversity amongst South African participants enrolled on the AVIP study (2008) (0)
The epidemiology and molecular characterstics of hepatitis B virus infection in children from a hyperendemic area of South Africa, including a field trial of the hepatitis B immunization programme and its impact on infection in this population (2014) (0)
Coxsackievirus Infections (2017) (0)
AIDS vaccine integrated project (AVIP): a consortium funded by the FP-6 EU program (2006) (0)
PREPARING FOR PHASE I/II HIV VACCINE TRIALS IN SOUTH AFRICA AND PLANNING FOR PHASE III TRIALS (2004) (0)
Cross-clade recognition of structural and regulatory HIV-1 antigens and virus neutralization by sera from HIV-infected South African subjects (2008) (0)

This paper list is powered by the following services:

Other Resources About Eftyhia Vardas

en.wikipedia.org

What Schools Are Affiliated With Eftyhia Vardas?

Eftyhia Vardas is affiliated with the following schools:

Eftyhia Vardas's Academic­Influence.com Rankings

Why Is Eftyhia Vardas Influential?

Eftyhia Vardas's Published Works

Published Works

Other Resources About Eftyhia Vardas

What Schools Are Affiliated With Eftyhia Vardas?

Eftyhia Vardas's AcademicInfluence.com Rankings